why choose us

First received: June 03, 2023

Clinical Trial: Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Iron-deficiency

Study Type: INTERVENTIONAL


Official Title: A Randomised, Double-blind Study to Determine the Safety and Efficacy of IHAT in Iron Deficient Premenopausal Women.

Brief Summary: This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed IHAT (iron hydroxide adipate tartrate) at 2 different doses compared to placebo for increasing serum ferritin levels in iron-deficient but otherwise healthy premenopausal women over 12 weeks.

Read more